These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24147144)

  • 1. Evaluation of hepatitis A vaccine in post-exposure prophylaxis, The Netherlands, 2004-2012.
    Whelan J; Sonder GJ; Bovée L; Speksnijder A; van den Hoek A
    PLoS One; 2013; 8(10):e78914. PubMed ID: 24147144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field effectiveness of hepatitis A vaccine and uptake of post exposure prophylaxis following a change to the Australian guidelines.
    Freeman E; Lawrence G; McAnulty J; Tobin S; MacIntyre CR; Torvaldsen S
    Vaccine; 2014 Sep; 32(42):5509-13. PubMed ID: 25111168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis.
    Parrón I; Planas C; Godoy P; Manzanares-Laya S; Martínez A; Sala MR; Minguell S; Torner N; Jané M; Domínguez A;
    Hum Vaccin Immunother; 2017 Feb; 13(2):423-427. PubMed ID: 27925847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Financial Burden of Public Health Responses to Hepatitis A Cases Among Food Handlers, 2012-2014.
    Morey RJ; Collier MG; Nelson NP
    Public Health Rep; 2017; 132(4):443-447. PubMed ID: 28609202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
    Nelson NP; Link-Gelles R; Hofmeister MG; Romero JR; Moore KL; Ward JW; Schillie SF
    MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(43):1216-1220. PubMed ID: 30383742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial.
    Sagliocca L; Amoroso P; Stroffolini T; Adamo B; Tosti ME; Lettieri G; Esposito C; Buonocore S; Pierri P; Mele A
    Lancet; 1999 Apr; 353(9159):1136-9. PubMed ID: 10209977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40 years of age: A systematic review of published studies and recommendations for vaccine use.
    Link-Gelles R; Hofmeister MG; Nelson NP
    Vaccine; 2018 May; 36(20):2745-2750. PubMed ID: 29673941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis.
    Victor JC; Monto AS; Surdina TY; Suleimenova SZ; Vaughan G; Nainan OV; Favorov MO; Margolis HS; Bell BP
    N Engl J Med; 2007 Oct; 357(17):1685-94. PubMed ID: 17947390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declining incidence of hepatitis A in Amsterdam (The Netherlands), 1996-2011: second generation migrants still an important risk group for virus importation.
    Whelan J; Sonder G; van den Hoek A
    Vaccine; 2013 Apr; 31(14):1806-11. PubMed ID: 23395735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying effects of postexposure hepatitis A active immunization.
    Mimouni D; Bar-Zeev Y; Davidovitch N; Zarka S
    Mil Med; 2006 Dec; 171(12):1196-7. PubMed ID: 17256681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the control of hepatitis A virus infection.
    Crowcroft NS; Walsh B; Davison KL; Gungabissoon U;
    Commun Dis Public Health; 2001 Sep; 4(3):213-27. PubMed ID: 11732363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years.
    Vizzotti C; González J; Rearte A; Urueña A; Pérez Carrega M; Calli R; Gentile A; Uboldi A; Ramonet M; Cañero-Velasco M; Diosque M
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e62-7. PubMed ID: 26582885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health management of invasive meningococcal disease in Baden-Wuerttemberg, Germany, 2012: adherence to guidance and estimation of resources required as determined in a survey of local health authorities.
    Murajda L; Aichinger E; Pfaff G; Hellenbrand W
    BMC Public Health; 2015 Apr; 15():371. PubMed ID: 25881238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May-July 2022.
    van Ewijk CE; Smit C; Bavalia R; Ainslie K; Vollaard A; van Rijckevorsel G; Hahné SJM
    Vaccine; 2023 Nov; 41(47):6952-6959. PubMed ID: 37838481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of vaccination in preventing secondary cases of hepatitis A virus infection.
    Sagliocca L; Bianco E; Amoroso P; Quarto M; Richichi I; Tosti ME; Carannante N; Chironna M; Chiriacò P; Di Bari G; Lopalco P; Resta F; Santantonio T; Tantimonaco G; Mele A
    Vaccine; 2005 Jan; 23(7):910-4. PubMed ID: 15603892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients.
    Arslan M; Wiesner RH; Poterucha JJ; Zein NN
    Transplantation; 2001 Jul; 72(2):272-6. PubMed ID: 11477352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.